SCHEMBL3452164

SCHEMBL3452164

OC1CCN(c2cc(-c3ccccc3)nc(Nc3ccccc3)n2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 4/20 0.48
HRH1 P35367 3/20 0.48
HRH2 P25021 1/20 0.48
HRH3 Q9Y5N1 1/20 0.48
IDH2 P48735 2/20 0.46
HPGD P15428 1/20 0.46
SMG1 Q96Q15 1/20 0.46
KMT2A Q03164 3/20 0.45
MAPT P10636 3/20 0.45
LMNA P02545 3/20 0.45
KDM4E B2RXH2 2/20 0.45
MEN1 O00255 2/20 0.45
ALDH1A1 P00352 2/20 0.45
GLA P06280 2/20 0.45
POLB P06746 2/20 0.45
GAA P10253 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SYK P43405 1/20 0.44
TSHR P16473 2/20 0.44
HSD17B10 Q99714 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3450492 0.93 HRH4 (0.45) HRH4HRH1HRH2HRH3IDH2
SCHEMBL13126895 0.90 CDK1 (0.48) HRH4HRH1HRH2HRH3IDH2
SCHEMBL3451124 0.89 HRH4 (0.44) HRH4HRH1HRH2HRH3IDH2
SCHEMBL3451248 0.88 MAPK8 (0.54) HRH4HRH1HRH2HRH3HPGD
SCHEMBL3450957 0.88 PTGS2 (0.47) HRH4HRH1HRH2HRH3HPGD
SCHEMBL3452091 0.87 PTGS2 (0.52) HRH4HRH1HRH2HRH3JAK2
SCHEMBL3452008 0.87 IKBKB (0.53) SMG1KMT2AMAPTMEN1HTT
SCHEMBL3453662 0.87 IDH2 (0.67) IDH2SMG1MAPT
SCHEMBL3451118 0.87 JAK2 (0.61) HRH4HRH1HRH2HRH3HPGD
Hydrochloric Acid SCHEMBL3450859 0.87 PTGS2 (0.46) HRH4HRH1HRH2HRH3HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820654-B2 Pyrimidine compounds, process for their preparation and compositions containing them DR. REDDY'S LABORATORIES LTD. (IN) 2010-10-26 US claimed
EP-1796673-A2 NOVEL PYRIMIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM Reddy US Therapeutics, Inc. (US) 2007-06-20 EP claimed
US-20060084645-A1 Novel pyrimidine compounds, process for their preparation and compositions containing them DR. REDDY'S LABORATORIES LTD. (IN) 2006-04-20 US claimed
WO-2006034473-A2 NOVEL PYRIMIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM REDDY US THERAPEUTICS, INC. (US) 2006-03-30 WO claimed
US-7820654-B2 Pyrimidine compounds, process for their preparation and compositions containing them DR. REDDY'S LABORATORIES LTD. (IN) 2010-10-26 US disclosed
US-7820654-B2 Pyrimidine compounds, process for their preparation and compositions containing them DR. REDDY'S LABORATORIES LTD. (IN) 2010-10-26 US disclosed
US-7820654-B2 Pyrimidine compounds, process for their preparation and compositions containing them DR. REDDY'S LABORATORIES LTD. (IN) 2010-10-26 US disclosed
US-20060084645-A1 Novel pyrimidine compounds, process for their preparation and compositions containing them DR. REDDY'S LABORATORIES LTD. (IN) 2006-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084645-A1 Novel pyrimidine compounds, process for their preparation and compositions containing them UMPS, DPYD, TYMS HRH4 2405/4885HRH1 2475/4885HRH2 2235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.